New Frontiers in Subcutaneous Immunoglobulin Treatment

Subcutaneous immunoglobulin (SCIG) treatment provides stable serum immunoglobulin G (IgG) levels, is associated with fewer systemic adverse events than intravenous immunoglobulin (IVIG) treatment, and offers the convenience of home therapy. In clinical practice, IVIG is still used preferentially for...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Jolles, Stephen, Stein, Mark R., Longhurst, Hilary J., Borte, Michael, Ritchie, Bruce, Sturzenegger, Matthias H., Berger, Melvin
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Healthcare Communications 2011
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3873072/
https://ncbi.nlm.nih.gov/pubmed/24392293
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13554-011-0009-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados